VC firm
Lumira Ventures
- Investor type
- VC
- Investing status
- Activeas of 2026-09-17Source (opens in a new tab)
- Headquarters
- Toronto, ON, Canada
- Assets under management
- $66.6MForm ADV private fund GAV, as of 2026-03-30Source (opens in a new tab)
- Funds
- 8
- Legal name
- Lumira Capital Investment Management Inc.
Claim, correct or request removal
Record updated 29 September 2026
About
We partner with mission-driven entrepreneurs to build transformative life sciences companies focused on developing and commercializing impactful products for patients
Investment approach
- Thesis
- Our mission is to deliver exceptional returns for investors by investing in and helping to create value in transformative life sciences companies. In achieving this goal, we have consistently built companies delivering impact to patients and healthcare systems worldwide.Source (opens in a new tab)
- Investing status notes
- Cancer Breakthrough Fund Invests in Altis Labs' $25MM Series A
Funds
- LUMIRA VENTURES IV (INTERNATIONAL), L.P.
- Main fund
- LUMIRA CAPITAL II (INTERNATIONAL), L.P.
- Main fund
- LUMIRA VENTURES III (INTERNATIONAL), L.P.
- Main fund
- LUMIRA CAPITAL (USA), L.P.
- Main fund
- LUMIRA VENTURES III GP, L.P.
- Main fund
- MERCK LUMIRA BIOSCIENCES FUND, L.P.
- Main fund
- LUMIRA VENTURES IV HOLDING LP
- Main fund
- LUMIRA CAPITAL GP, L.P.
- Main fund
SEC registration
- Registered adviser
- LUMIRA CAPITAL INVESTMENT MANAGEMENT INC.
- CRD number
- 164152 (opens in a new tab)
- SEC file number
- 802-78731
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $66.6Mas of 2026-03-30
- Private funds reported
- 8
- Principal office
- TORONTO, ONTARIO, Canada
Locations
- Headquarters
- Toronto, ON, Canada
- Office
- Montreal, QC, Canada
Loading relationship preview